Viltepso (viltolarsen) for Duchenne muscular dystrophy
Viltepso (viltolarsen) is an FDA-approved weekly infusion treatment for Duchenne MD patients with mutations amenable to exon 53 skipping.
Viltepso (viltolarsen) for Duchenne muscular dystrophy
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
